ABBV
AbbVie Inc.
NYSE Pharmaceutical Preparations Large accelerated filer

Key Financials

Net Income
$4.2B
↑ 132.7%
Gross Profit
$12.1B
↑ 12.7%
Operating Income
$15.1B
↑ 65.0%
Revenue
$61.2B
↑ 268.0%
EPS (Diluted)
$2.36
↑ 131.4%
Cash & Equivalents
$5.2B
↓ 5.3%
Total Assets
$134.0B
↓ 0.9%
Shareholders' Equity
$-3270000000.00
↓ 198.3%

Recent SEC Filings

Form Type Filed Date Link
8-K 4/3/2026 View on SEC
4 4/2/2026 View on SEC
4 4/2/2026 View on SEC
4 4/2/2026 View on SEC
SCHEDULE 13G/A 3/26/2026 View on SEC
ARS 3/23/2026 View on SEC
DEFA14A 3/23/2026 View on SEC
DEF 14A 3/23/2026 View on SEC
4/A 3/11/2026 View on SEC
PRE 14A 3/9/2026 View on SEC

Company Information

Field Value
Ticker ABBV
Company Name AbbVie Inc.
CIK 1551152
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange NYSE
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (847) 932-7900